Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

127.57
BATS BZX Real-Time Price
As of 9:54am ET
 +0.05 / +0.04%
Today’s Change
109.32
Today|||52-Week Range
129.00
+10.73%
Year-to-Date
JNJ Regular Dividend: JNJ will begin trading ex-dividend on 05/25/17 with a $0.84 dividend payable to shareholders of record as of 05/30/17.
Here's Why Alexion Pharma (ALXN) Stock is Sinking Today
May 23 / Zacks.com - Paid Partner Content
Why Is Johnson & Johnson (JNJ) Up 4.4% Since the Last Earnings Report?
May 19 / Zacks.com - Paid Partner Content
Chinese tech companies top world in trademark applications
May 22 / FT.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Home Depot, Cisco, Wal-Mart Beat on Earnings
May 19 / Zacks.com - Paid Partner Content
The Active vs. Passive Performance Debate Is Nonsensical
May 18 / GuruFocus News - Paid Partner Content
Johnson & Johnson Unit Sues to Block Sale of Copy of its Rheumatoid Arthritis Drug
May 19 / TheStreet.com - Paid Partner Content
J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021
May 18 / Zacks.com - Paid Partner Content
The Dollar Breakdown Has Legs
May 19 / TheStreet.com - Paid Partner Content
Shares of Colgate-Palmolive (CL) Pop as CEO May Want to Sell
May 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close127.52
Today’s open127.51
Day’s range127.47 - 127.99
Volume30,112
Average volume (3 months)6,524,217
Market cap$343.5B
Dividend yield2.63%
Data as of 9:54am ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+8.21%
Earnings growth (this year)+5.42%
Earnings growth (next 5 years)+5.95%
Revenue growth (last year)+2.47%
P/E ratio21.5
Price/Sales4.47
Price/Book4.90

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.02-0.05%
NVSNovartis-0.02-0.02%
MRKMerck+0.35+0.54%
SNYSanofi-0.04-0.08%
Data as of 9:54am ET, 05/24/2017

Financials

Next reporting dateJuly 18, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$71.9B
Annual profit (last year)$16.5B
Net profit margin22.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts